BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 24, 2017
View Archived Issues
Janssen describes anxiolytic candidate JNJ-54717793, a selective Ox1R antagonist
Read More
Genentech discovers new, potent and selective inhibitors of Nav1.7
Read More
Grid Therapeutics signs license agreement with Duke University for CFH antibodies for cancer
Read More
Inactivation of PERVs to eliminate cross-species viral transmission in xenotransplantation
Read More
Novel VLP zDIII-based subunit Zika vaccine demonstrates high immunogenicity in mice
Read More
Teikoku Pharma reports topline phase II results for TPU-006 patch in post-surgical pain
Read More
Apic Bio launches with focus on therapies for alpha-1 antitrypsin deficiency
Read More
GT Biopharma announces reverse stock split
Read More
Novel series of GyrB/ParE inhibitors discovered for bacterial infections including gonorrhea
Read More
Cure Pharmaceutical reports progress in development of ODS formulation of isoniazid
Read More
FDA grants orphan drug designation to EPX-300 for Dravet syndrome
Read More
Emcure Pharmaceuticals presents new IDO-1, TDO inhibitors
Read More
Intra-Cellular Therapies receives FDA opinion on lumateperone program in schizophrenia
Read More
Novel retinoic acid receptor ligands discovered at Galderma
Read More
ViiV Healthcare divulges new HIV maturation inhibitors
Read More
Bamichem, Samjin Pharmaceutical, Incheon National University patent VEGFR-2, B-Raf, C-Raf inhibitors
Read More
GlaxoSmithKline discovers new phosphatidylinositol 3-kinase inhibitors
Read More
Caprion collaborates with FNIH Biomarkers Consortium on Cerebrospinal Fluid Proteomics Project
Read More
Otsuka and Mylan sign delamanid license agreement for low- and middle-income countries
Read More
Symic Bio initiates phase II MODIFY2 study of SB-061 for osteoarthritis
Read More
E.U. approval for Kisqali with an aromatase inhibitor for first-line HR+/HER- breast cancer
Read More
ImmunoCellular refocuses resources on Stem-to-T-Cell research program
Read More
FDA grants priority review to emicizumab BLA for hemophilia A
Read More
Orchard's OTL-101 designated Promising Innovative Medicine in U.K. for ADA-SCID
Read More
First-in-human study evaluates fluorothyazinone in healthy volunteers
Read More
Daewoong studies DWP-14012 for erosive GERD in new phase II trial
Read More
Bonti initiates phase II LANTERN-1 study of EB-001 to reduce musculoskeletal pain
Read More